Daniell Richard — SEC Form 4 filings
SEC reporting owner CIK 1726096. 15 Form 4 filings on record with FilingPulse; latest filed 2026-05-07.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-01 to 2026-05-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 12 filings — 920,609 shares, $20,339,833 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 115,468 shares @ $28.68 ($3,311,126) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2025-12-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | 15 | — | 24 legs · 920,609 sh · $20,339,833 | 40 |
Form 4 filings — Daniell Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 30,000 @ $35.40 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Sale (S): 33,512 @ $32.46 · Option exercise (M): 20,461 · Sale (S): 20,461 @ $32.46 · Sale (S): 37,372 @ $32.95 · Option exercise (M): 33,512 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 62,250 · Sale (S): 62,250 @ $32.36 · Option exercise (M): 141,478 · Sale (S): 66,735 @ $32.36 · Option exercise (M): 62,250 (derivative) @ $0 · Option exercise (M): 141,478 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 141,478 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 100,457 @ $18.61 · Option exercise (M): 15,011 @ $16.99 · Sale (S): 115,468 @ $28.68 · Option exercise (M): 100,457 (derivative) @ $0 · Option exercise (M): 15,011 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 22,576 · Sale (S): 22,576 @ $15.91 · Sale (S): 48,385 @ $15.90 · Option exercise (M): 22,576 (derivative) @ $0 · Grant/award (A): 69,182 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Sale (S): 21,870 @ $15.73 · Sale (S): 11,641 @ $15.91 · Option exercise (M): 20,461 · Sale (S): 13,353 @ $15.73 · Sale (S): 7,108 @ $15.91 · +6 more | EDGAR |
| 2025-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 62,250 · Sale (S): 49,314 @ $16.19 · Sale (S): 12,936 @ $15.56 · Option exercise (M): 62,250 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 183,169 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 98,943 @ $17.30 | EDGAR |
| 2024-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 22,576 · Sale (S): 22,576 @ $13.52 · Option exercise (M): 55,226 · Sale (S): 26,053 @ $13.52 · Option exercise (M): 22,576 (derivative) @ $0 · Option exercise (M): 55,226 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 62,250 · Sale (S): 62,250 @ $13.34 · Option exercise (M): 33,512 · Sale (S): 33,512 @ $13.34 · Option exercise (M): 62,250 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,599 · Sale (S): 20,599 @ $13.12 · Option exercise (M): 20,599 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 55,226 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1726096 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →